KIT (AML) Targeted Gene Analysis Exons 8, 17 with Interpretation
6004 BT GH
Whole Blood, Bone Marrow
3 mL of whole blood or bone marrow aspirate. Specimens for which
the AML blast count is at least 10% will be tested. Testing on smaller
volumes may be attempted. However, this may compromise the ability to
perform testing. Testing requires a dedicated collection tube.
Testing is generally not available on a STAT basis. However,
expedited testing can be arranged by contacting the Molecular
Pathology Laboratory at 384-9568 or the Molecular Genetic Pathology
Fellow (pager #8682).
0800-1700 Testing offered once per week
excluding weekends and University holidays.
7-10 working days
KIT AML Mutation Analysis detected exons related to patients with
If patient has GIST or melanoma, order KIT Mutation Analysis
(LAB7660). This is a sequence-based assay. This test is not intended
to detect the D816 mutation in bone marrow for mast cell disease or to
detect minimal residual disease (see KIT Mutation (D816V) Mast Cell
Massively parallel Next Generation DNA sequencing by synthesis,
semiconductor technology, Ion Personal Genomics Machine.